Issues in methodology and applications for therapeutic drug monitoring of fluoxetine and norfluoxetine enantiomers

Therapeutic Drug Monitoring

Volumn 20, Issue 1, 1998, Pages 20-24

  Zuccaro, P ^a   Pacifici, R ^a   Altieri, I ^a   Avenoso, A ^b   Pellegrini, M ^a   Spina, E ^b   Perucca, E ^b   Pichini, S ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NONE

Author keywords

Biologic fluids; Enantiomers; Fluoxetine; Norfluoxetine; Stability; Stereoselective HPLC

Indexed keywords

EDETIC ACID; FLUOXETINE; NORFLUOXETINE; SODIUM HYDROXIDE;

ARTICLE; DRUG DETERMINATION; DRUG MONITORING; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; RELIABILITY; SOLID PHASE EXTRACTION; STANDARDIZATION; STEREOCHEMISTRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; FLUOXETINE; HUMANS; SEROTONIN UPTAKE INHIBITORS; STEREOISOMERISM;

EID: 0031911755     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199802000-00004     Document Type: Article

References (21)

1. Stark P, Fuller RW, Wong DT. The pharmacologic profile of fluoxetine. J Clin Psychiatry 1985;46:7-13.
2. Lemberger L, Bergstrom RW, Wolen RL, et al. Fluoxetine: clinical pharmacology and physiologic disposition. J Clin Psychiatry 1985; 46:14-9.
3. Harris MG, Benfield P. Fluoxetine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness. Drugs Aging 1995;6:64-84.
4. Beasley CM, Bosomworth JC, Wernicke JF. Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depression. Psychopharmacol Bull 1990;26:18-24.
5. Van Harten J. Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin Pharmacokinet 1993;24:203-20.
6. Altamura AC, Moro AR, Percudani M. Clinical pharmacokinetics of fluoxetine. Clin Pharmacokinet 1994;26:201-14.
7. Wong DT, Bymaster FP, Reid RR, Fuller RW, Perry KW. Inhibition of serotonin uptake byoptical isomers of fluoxetine. Drug Dev Res 1985;6:397-403.
8. Robertson DW, Krushinski JH, Fuller RW, Leander JD. Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor. J Med Chem 1988;31:1412-7.
9. Robertson DW, Jones ND, Swartzendruber JK, Yang KS, Wong DT. Molecular structure of fluoxetine hydrochloride, a highly selective serotonin-uptake inhibitor. J Med Chem 1988;31:185-9.
10. Fuller RW, Wong DT, Robertson DW. Fluoxetine, a selective inhibitor of serotonin uptake. Med Res Rev 1990;11:17-34.
11. Nash JF, Bopp RJ, Carmichael RH, Farid KZ, Lemberger L. Determination of fluoxetine and norfluoxetine in plasma by gas chromatography with electron-capture detection. Clin Chem 1982;28: 2100-2.
12. Orsulak PJ, Kenney JT, Debus JR, Crowley G, Wittman PD. Determination of antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC, with ultraviolet detection. Clin Chem 1988;34:1875-8.
13. Wong SHY, Dellafera SS, Fernandez R, Kranzler H. Determination of fluoxetine and norfluoxetine by high-performance liquid chromatography. J Chromatogr 1990;499:601-8.
14. Gupta RN, Steiner M. Determination of fluoxetine and norfluoxetine in serum by liquid chromatography with fluorescence detection. J Liq Chromatogr 1990;13:3785-97.
15. Dixit V, Nguyen H, Dixit VM. Solid-phase extraction of fluoxetine and norfluoxetine from serum with gas-chromatography-electron capture detection. J Chromatogr 1991;563:379-84.
16. El-Maanni A, Combourieu I, Bonini M, Creppy EE. Fluoxetine, an antidepressant, and norfluoxetine, its metabolite, determined by HPLC with C8 column and ultraviolet detection. Clin Chem 1993; 39:1749-50.
17. El-Yazigi A, Raines DA. Concurrent liquid chromatographic measurement of fluoxetine, amitriptyline, imipramine, and their active metabolites norfluoxetine, nortriptyline, and desipramine in plasma. Ther Drug Monit 1993;15:305-9.
18. Nichols JH, Charlson JR, Lawson GM. Automated HPLC assay of fluoxetine and norfluoxetine in serum. Clin Chem 1994;40: 1312-6.
19. Potts BD, Parli CJ. Analysis of the enantiomers of fluoxetine and norfluoxetine in plasma and tissue using chiral derivatization and normal-phase liquid chromatography. J Liq Chromatogr 1994;15: 665-81.
20. Torok-Both GA, Baker GB, Coutts RT, McKenna KF, Aspeslet LJ. Simultaneous determination of fluoxetine and norfluoxetine enantiomers in biological samples by gas-chromatography with electron-capture detection. J Chromatogr 1992;579:99-106.
21. Pichini S, Pacifici R, Altieri I, Pellegrini M, Zuccaro P. Stereoselective determination of fluoxetine and norfluoxetine enantiomers in plasma samples by high-performance liquid chromatography. J Liq Chromatogr 1996;19:1927-35.